BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 27542332)

  • 1. Nitrofurantoin's efficacy and safety as prophylaxis for urinary tract infections: a systematic review of the literature and meta-analysis of controlled trials.
    Muller AE; Verhaegh EM; Harbarth S; Mouton JW; Huttner A
    Clin Microbiol Infect; 2017 Jun; 23(6):355-362. PubMed ID: 27542332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials.
    Huttner A; Verhaegh EM; Harbarth S; Muller AE; Theuretzbacher U; Mouton JW
    J Antimicrob Chemother; 2015 Sep; 70(9):2456-64. PubMed ID: 26066581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrofurantoin vs other prophylactic agents in reducing recurrent urinary tract infections in adult women: a systematic review and meta-analysis.
    Price JR; Guran LA; Gregory WT; McDonagh MS
    Am J Obstet Gynecol; 2016 Nov; 215(5):548-560. PubMed ID: 27457111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term antibiotics for preventing recurrent urinary tract infection in children.
    Williams GJ; Wei L; Lee A; Craig JC
    Cochrane Database Syst Rev; 2006 Jul; (3):CD001534. PubMed ID: 16855971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term antibiotics for preventing recurrent urinary tract infection in children.
    Williams GJ; Lee A; Craig JC
    Cochrane Database Syst Rev; 2001; (4):CD001534. PubMed ID: 11687116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prophylaxis of recurrent urinary tract infections in children. Results of an open, controlled and randomized study about the efficacy and tolerance of cefixime compared to nitrofurantoin].
    Lettgen B; Tröster K
    Klin Padiatr; 2002; 214(6):353-8. PubMed ID: 12424684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of recurrent urinary infections in women: a comparative trial between nitrofurantoin and methenamine hippurate.
    Brumfitt W; Cooper J; Hamilton-Miller JM
    J Urol; 1981 Jul; 126(1):71-4. PubMed ID: 7019458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrofurantoin-induced lung disease and prophylaxis of urinary tract infections.
    Madani Y; Mann B
    Prim Care Respir J; 2012 Sep; 21(3):337-41. PubMed ID: 22836745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years' experience.
    Brumfitt W; Hamilton-Miller JM
    J Antimicrob Chemother; 1998 Sep; 42(3):363-71. PubMed ID: 9786476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methenamine hippurate for preventing urinary tract infections.
    Lee B; Bhuta T; Craig J; Simpson J
    Cochrane Database Syst Rev; 2002; (1):CD003265. PubMed ID: 11869659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methenamine hippurate for preventing urinary tract infections.
    Lee BS; Bhuta T; Simpson JM; Craig JC
    Cochrane Database Syst Rev; 2012 Oct; 10(10):CD003265. PubMed ID: 23076896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral antibiotics to prevent postoperative urinary tract infection: a randomized controlled trial.
    Dieter AA; Amundsen CL; Edenfield AL; Kawasaki A; Levin PJ; Visco AG; Siddiqui NY
    Obstet Gynecol; 2014 Jan; 123(1):96-103. PubMed ID: 24463669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term antibiotics for the prevention of recurrent urinary tract infection in children: a systematic review and meta-analysis.
    Dai B; Liu Y; Jia J; Mei C
    Arch Dis Child; 2010 Jul; 95(7):499-508. PubMed ID: 20457696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrofurantoin 100 mg versus 50 mg prophylaxis for urinary tract infections, a cohort study.
    Ten Doesschate T; Hendriks K; van Werkhoven CH; van der Hout EC; Platteel TN; Groenewegen IAM; Muller AE; Hoepelman AIM; Bonten MJM; Geerlings SE
    Clin Microbiol Infect; 2022 Feb; 28(2):248-254. PubMed ID: 34111584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nitrofurantoin--clinical relevance in uncomplicated urinary tract infections].
    Stock I
    Med Monatsschr Pharm; 2014 Jul; 37(7):242-8. PubMed ID: 25065160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung toxicity and Nitrofurantoin: the tip of the iceberg?
    Weir M; Daly GJ
    QJM; 2013 Mar; 106(3):271-2. PubMed ID: 22836192
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of nitrofurantoin and methenamine hippurate prophylaxis on bacteria and yeasts in the urine of patients with an indwelling catheter.
    Kostiala AA; Nyrén P; Runeberg L
    J Hosp Infect; 1982 Dec; 3(4):357-64. PubMed ID: 6190868
    [No Abstract]   [Full Text] [Related]  

  • 18. Interventions for preventing recurrent urinary tract infection during pregnancy.
    Schneeberger C; Geerlings SE; Middleton P; Crowther CA
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009279. PubMed ID: 23152271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of estriol-containing vaginal pessaries and nitrofurantoin macrocrystal therapy in the prevention of recurrent urinary tract infection in postmenopausal women.
    Raz R; Colodner R; Rohana Y; Battino S; Rottensterich E; Wasser I; Stamm W
    Clin Infect Dis; 2003 Jun; 36(11):1362-8. PubMed ID: 12766829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial.
    Kranjčec B; Papeš D; Altarac S
    World J Urol; 2014 Feb; 32(1):79-84. PubMed ID: 23633128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.